Maximizing the clinical benefit of novel therapies in multiple myeloma.
Laubach
Jacob
J
Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Mitsiades
Constantine
C
Anderson
Kenneth
K
Richardson
Paul
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D009101:Multiple Myeloma / Q000628:therapy*; D033581:Stem Cell Transplantation